In ₹ Crore except Per Share Latest Annual | 3BBLACKBIO FY25 | HEALTHX FY26 | SURAKSHA FY26 | KRSNAA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | 824.32× | 52.78× | ◆ 18.00× | 52.78× | |
| P/B | — | ◆ 1.27× | 6.98× | 1.86× | 1.86× | |
| EV/EBITDA | — | — | 17.79× | ◆ 11.01× | 14.40× | |
| Market Cap | — | ₹970 Cr | ₹1,699 Cr | ₹1,828 Cr | ₹1,699 Cr | |
| Growth | ||||||
| Revenue CAGR 3Y | — | 8.26% | — | ◆ 16.63% | 12.45% | |
| Revenue CAGR 5Y | — | 19.20% | — | — | 19.20% | |
| Net Income CAGR 3Y | — | — | — | 17.76% | 17.76% | |
| Revenue YoY (latest Q) | — | ◆ 49.73% | 20.75% | 22.05% | 22.05% | |
| Net Income YoY (latest Q) | — | -92.53% | ◆ 40.00% | -19.34% | -19.34% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 55.07% | -3.95% | 30.73% | 27.42% | 27.42% +101% | |
| Net Income Margin | ◆ 52.53% | -0.11% | 10.12% | 13.13% | 10.12% +419% | |
| Return on Common Equity | ◆ 17.43% | 0.15% | 13.22% | 10.35% | 10.35% +68% | |
| Return on Capital Employed | ◆ 17.57% | — | 13.89% | 7.84% | 10.87% +62% | |
| Return on Assets | ◆ 16.01% | -0.15% | 7.01% | 5.56% | 5.56% +188% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | — | 0.01× | 0.55× | 0.28× -100% | |
| Interest Coverage | ◆ 506.18× | -75.12× | 4.30× | 3.53× | 3.53× +14239% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹90.5 Cr | ₹1,319 Cr | ₹310 Cr | ₹773 Cr | ₹773 Cr -88% | |
| Net Income | ₹47.6 Cr | −₹1.4 Cr | ₹31.4 Cr | ₹101 Cr | ₹31.4 Cr +51% | |
| Total Assets | ₹297 Cr | ₹936 Cr | ₹448 Cr | ₹1,824 Cr | ₹936 Cr -68% | |
| EPS | — | ₹0.37 | ₹6.18 | ₹31.3 | ₹6.18 | |
| Book Value per Share | — | ₹240.57 | ₹46.75 | ₹302.23 | ₹240.57 | |